miscsubjectsAI governance
Evidence review

SS-31 (Elamipretide) for Chemotherapy-Induced Neuropathy: Evidence Review

· · 4 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-chemo-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-chemo-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-chemo-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-chemo-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-chemo-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-chemo-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why SS-31 (Elamipretide) might help you

  1. You are reading about Chemotherapy-induced neuropathy (CIPN) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

Why Gabapentin / pregabalin matters for you

  1. Drug: Gabapentin / pregabalin
  2. What it does: Masks neuropathic pain signal; does not repair nerve.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 5
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.41 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice (source s1)

2018 mouse study showing SS-20 (related mitochondrial peptide) prevented CIPN behaviors and nerve fiber loss with oxaliplatin.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Mini-Review: Mitochondrial Dysfunction and Chemotherapy-Induced Peripheral Neuropathy (source s2)

Review linking mitochondrial injury to CIPN mechanisms.

Evidence type: Published research.

Mitochondrial dysfunction: an emerging therapeutic target for chemotherapy-induced peripheral neuropathy (source s3)

Review citing only preclinical attenuation; no human CIPN trials noted.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms (source s4)

Mechanism of gabapentinoids on calcium channels and neurotransmitter release.

Evidence type: Published research.

Gabapentinoids for chemotherapy-induced peripheral neuropathy (source s5)

Assessment of limited and inconsistent evidence for gabapentinoids in CIPN.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Neuropathy (general) · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedSS-31 (Elamipretide) Mitochondrial Targeting with GLP-1 Agonists: Evid… · 3 humanSS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence… · 2 humanSS-31 (Elamipretide) for Carpal Tunnel Syndrome: Mitochondrial Evidenc… · 2 humanSS-31 (Elamipretide) for Chemotherapy Side Effects: Mitochondrial Evid… · 2 human
Evidence · 5 sources · swipe →chain d554742bf8f2 · verify chain · provenance
1 / 5
Evidence ledger 5 · tier-ranked · API
preclinical
In oxaliplatin-treated mice, continuous SS-20 preserved intraepidermal nerve fiber density and reduced mechanical and cold hypersensitivity compared with vehicle.
sources: s1
mechanistic
Gabapentin and pregabalin reduce excitatory neurotransmitter release via alpha-2-delta calcium channel binding but do not repair nerves.
sources: s4
humanlow confidence
No human clinical trials have tested SS-31 for CIPN.
sources: s3
humanlow confidence
Evidence for gabapentinoids in CIPN is limited and inconsistent per reviews and guidelines.
sources: s5
mechanisticlow confidence
Mitochondrial dysfunction and oxidative stress contribute to axonal degeneration in CIPN.
sources: s2
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:58
SS-31 (Elamipretide) for Chemotherapy-Induced Neuropathy: Evidence Review · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Chemo Neuropathy
Slug: ss-31-chemo-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"Chemotherapy-induced neuropathy (CIPN)","condition_key":"chemo-neuropathy","primary_peptide":"ss-31","peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":["gabapentin-lyrica"],"weight_sensitive":false,"stimulant_context":fa
it output
{
  "slug": "ss-31-chemo-neuropathy",
  "title": "SS-31 (Elamipretide) for Chemotherapy-Induced Neuropathy: Evidence Review",
  "body": "## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy agents like oxaliplatin, paclitaxel, and vincristine damage peripheral nerves. This often shows up as tingling, numbness, burning pain, or cold sensitivity in hands and feet. The process starts with mitochondrial stress inside nerve cells. Chemo drugs disrupt the electron transport chain, raise reactive oxygen species, and lower ATP production. Axons then degenerate in a distal-to-proximal pattern. Intraepidermal nerve fibers in the skin thin out. Inflammation and oxidative damage compound the loss. Repair lags behind breakdown, so symptoms can persist months or years after treatment ends.\n\nMitochondrial dysfunction sits at the center. Nerves have high energy demand, especially the long axons and their terminals. When mitochondria fail, calcium handling breaks, ROS rises, and the cell cannot maintain structure. This matches the “dying-back” axon pattern seen in patients and animal models.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about Chemotherapy-induced neuropathy (CIPN) — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial dysfunction and oxidative stress in nerves form part of your p
f22ce376e40996d5
Machine verification: /api/articles/ss-31-chemo-neuropathy/contributions

Related articles

Neuropathy (general) · condition map

Open evidence map →
Ss 31ss-31SS-31 (Elamipretide) for Benzodiazepine Withdrawal: Mitochondrial Repa…ss-31-benzo-withdrawalSS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a…ss-31-benzodiazepinesSS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence…ss-31-brain-fogSS-31 (Elamipretide) for Carpal Tunnel Syndrome: Mitochondrial Evidenc…ss-31-carpal-tunnelSS-31 (Elamipretide) for Chemotherapy Side Effects: Mitochondrial Evid…ss-31-chemo
Ask this article · 7 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "In oxaliplatin-treated mice, continuous SS-20 preserved intraepidermal nerve fiber density and reduced mechanical and cold hypersensitivity …"?
ask ss-31-chemo-neuropathy claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "Gabapentin and pregabalin reduce excitatory neurotransmitter release via alpha-2-delta calcium channel binding but do not repair nerves."?
ask ss-31-chemo-neuropathy claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "No human clinical trials have tested SS-31 for CIPN."?
ask ss-31-chemo-neuropathy claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Evidence for gabapentinoids in CIPN is limited and inconsistent per reviews and guidelines."?
ask ss-31-chemo-neuropathy claim c5 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "Mitochondrial dysfunction and oxidative stress contribute to axonal degeneration in CIPN."?
ask ss-31-chemo-neuropathy claim c1 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) for Chemotherapy-Induced Neuropathy: Evidence Review — and what would you need me to tell you first?
ask ss-31-chemo-neuropathy condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) for Chemotherapy-Induced Neuropathy: Evidence Review (studies vs anecdotes)?
ask ss-31-chemo-neuropathy good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…